Last reviewed · How we verify
NCT04641650: FSL DIAL
Pilot Study : FreeStyle Libre Pro Flash Continuous Glucose Monitoring System in Subjects With Diabetes on HemoDIALsis
trial in Kidney Failure in 29 participants. Completed in 9 November 2022.
9 November 2022
Quick facts
| Lead sponsor | Centre Hospitalier Saint Joseph Saint Luc de Lyon |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 29 |
| Start date | 21 July 2021 |
| Primary completion | 9 November 2022 |
| Estimated completion | 9 November 2022 |
| Sites | 1 location across France |
Conditions studied
- Kidney Failure — all drugs for Kidney Failure →
- Diabetes — all drugs for Diabetes →
Sponsor
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Who can join
18 and older, any sex, with Kidney Failure or Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Continuous monitoring of glucose with a FreeStyle Libre pro sensor in diabetic and dialysis patients
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Diabetes technology in people with diabetes and advanced chronic kidney disease.
Galindo RJ, Soliman D, Cherñavvsky D, Rhee CM. · · 2024 · cited 10× · PMID 39112642 · DOI 10.1007/s00125-024-06244-y -
Continuous glucose monitoring with FreeStyle Libre PRO sensor in patients with type 2 diabetes and end-stage renal failure on haemoDIALysis (FSLPRO-DIAL pilot study).
Henry Z, Villar E, Chauvet C, Belloi A, et al · · 2024 · cited 2× · PMID 38922428 · DOI 10.1007/s00592-024-02323-z
Verify or expand the search:
- PubMed search for NCT04641650
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Failure
Currently open trials in the same condition.
- NCT07492511 — Renal and Hepatic Abnormal Doppler Patterns in Trauma · recruiting
- NCT06243731 — A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation · recruiting
- NCT06642597 — STarting incrEmental Prescription of Peritoneal Dialysis · NA · recruiting
- NCT06343727 — A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF) · NA · recruiting
- NCT07053462 — CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk · Phase 1, PHASE2 · recruiting
Other Centre Hospitalier Saint Joseph Saint Luc de Lyon trials
Trials by the same sponsor.
- NCT07312890 — Bedside Observation by Clinical Ultrasound for Stomach Expansion · NA · recruiting
- NCT07355777 — Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation · NA · recruiting
- NCT04827290 — Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease · NA · not yet recruiting
- NCT04422977 — Serological Study of the Exposure of Personnel to COVID-19 · NA · completed
- NCT04221282 — ZEBinix® Retention Rate in Epilepsy in Elderly Patients · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04641650 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Saint Joseph Saint Luc de Lyon
- Last refreshed: 4 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04641650.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing